Bioprinting Startup Next Big Innovation Labs named a World Economic Forum Technology Pioneer 2023

2 Mins read
NBIL chosen as World Economic Forum Technology Pioneer
NBIL chosen as a Technology Pioneer by World Economic Forum/Source: Next Big Innovation Labs

Next Big Innovation Labs (NBIL), a bioprinting pioneer, is the only Indian deep-tech company to be named a World Economic Forum Technology Pioneer this year. This prestigious award reaffirms NBIL’s commitment to driving transformative change in the world of regenerative medicine and demonstrates the company’s commitment to leveraging technology to reshape the future of healthcare and improve people’s lives around the world.

“We are incredibly honored and thrilled by World Economic Forums recognition and look forward to forging a multi- stakeholder collaboration towards addressing global health challenges. Our selection is a testament to NBIL’s groundbreaking work and unwavering commitment to leveraging technology to revolutionize bioprinting and positively impact the field of healthcare and testing.”

– Alok Medikepura Anil, Cofounder and Director, NBIL

World Economic Forum Technology Pioneer

The Technology Pioneer community, founded in 2000, is made up of early-stage start-ups from around the world involved in the development and deployment of new technologies and innovations. Every year, the World Economic Forum selects 100 companies to collaborate with society’s most influential political, business, and cultural leaders to address issues affecting people and the planet.

The World Economic Forum chooses 100 companies based on criteria such as Innovation, Impact, Leadership, Growth Stage, Funding, and Private. The cohorts for 2023 were just announced a few days ago, and only one Indian company is on the list.

The World Economic Forum Technology Pioneers programme is a two-year commitment to the organisation. Google, Twitter, Palantir Technologies, and other companies have previously been chosen.

Trivima – 3D Bioprinter Platform

Next Big Innovation Labs TRIVIMA line of bioprinters
Next Big Innovation Labs TRIVIMA line of bioprinters/Source: Next Big Innovation Labs

Next Big Innovation Labs TRIVIMA line of bioprinters/Source: Next Big Innovation Labs

Trivima, a 3D Bioprinter platform that is proudly Made in India, enables the fabrication of complex and functional human tissues and organs. In collaboration with the biosciences company HiMedia, NBIL has begun to scale its offerings globally and is actively expanding its network of collaborators in India and beyond.

“We look forward to engaging with like-minded visionaries, industry leaders, and experts to drive positive change and unlock the full potential of bioprinting. Together, we can forge a brighter future driven by innovation, sustainability, and social impact.”

– Piyush Padmanabhan, CEO and Cofounder, NBIL

NBIL is committed to forming partnerships with renowned research institutions and working closely with healthcare providers to translate innovative solutions in the 3D Bioprinting domain into real-world applications with large-scale positive societal impact.

“Next Big Innovation Labs has over the years proved that Indian Innovation can help meet Prime Minister’s vision for Atmanirbhar Bharat and kickstart a new era for Made In India and Built for the World.” – Dr. Chintan Vaishnav, Mission Director – AIM, NITI Aayog, Govt of India

“NBIL is defining the next generation of Innovation arising from our innovation- driven state of Karnataka. I am impressed with the growth of NBIL, recipients of the Government of Karnataka’s Idea2PoC (Elevate) grant to make bioprinters in India.” – Mr. Priyank Kharge, Minister for Information Technology and Biotechnology, Govt of Karnataka, India

“I congratulate Next Big Innovation Labs on their selection as a Technology Pioneer and appreciate their efforts to be torchbearers to the “Make In India” program, launched under my tenure at NITI Aayog.I wish NBIL a bright future ahead and look forward to them making India proud on the global stage.” – Mr. Amitabh Kant, Senior bureaucrat and India’s G20 Sherpa

“NBIL with its unique 3D Bioprinting offerings strikes a perfect cord with the growing innovation-driven demands of pharma companies in Switzerland. The World Economic Forum is a fantastic platform for cross-border collaboration and innovation. At Swissnex, we look forward to helping build stronger India – Swiss partnerships by supporting NBIL’s journey into Switzerland.” – Jonas Brunschwig – CEO | Consul General – Swissnex in India

About Manufactur3D: Manufactur3D is an online magazine on 3D Printing. Visit our Indian Scenario page for more updates on 3D Printing News from India. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn and Twitter.

284 posts

About author
Abhimanyu Chavan is the founder of Manufactur3D Magazine. He writes on Additive Manufacturing technology, interviews industry leaders, shares industry insights, and expresses his thoughts on the latest developments in the industry. You can follow him on LinkedIn, Twitter and Instagram.
Related posts

IIT Madras starts a 3D Printing Farm with 25+ FabMachines in its New Additive Manufacturing Lab

2 Mins read
IIT Madras has started a 3D printing farm with 25+ FabMachines 3D Printers developed by Fabheads Automation into its newly inaugurated

NITTE and Wipro3D establish Center of Excellence in Digital Manufacturing

2 Mins read
NITTE in collaboration with Wipro3D announced the establishment of a Centre of Excellence (CoE) in Digital Manufacturing. The ceremony took

STPL 3D unveils its Made in India SLS 3D printer at IMTEX 2024

2 Mins read
STPL 3D unveiled its latest 3D printing product, a Made in India SLS 3D printer – the INSS 500, at the ongoing IMTEX 2024 exhibition in Bengaluru